Updating results

73 results for IBD Sort: Relevance | Date

Inflammatory bowel disease (QS81)

This quality standard covers diagnosing and managing inflammatory bowel disease (Crohn’s disease and ulcerative colitis) in adults, young people and children. It describes high-quality care in priority areas for improvement.

Quality standard Published February 2015

MIB109: RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease

Advice on the use of RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (IBD) to aid local decision-making

Medtech innovation briefing Published June 2017

Leukapheresis for inflammatory bowel disease (IPG126)

Evidence-based recommendations on leukapheresis for inflammatory bowel disease (IBD) (ulcerative colitis and Crohn's disease)

Interventional procedures guidance Published June 2005

Inflammatory bowel disease

All NICE products on Inflammatory bowel disease. Includes any guidance, advice, NICE Pathways and quality standards.

Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas (CG118)

This guideline covers using colonoscopy to check for signs of bowel cancer in people aged 18 and over with ulcerative colitis or Crohn’s disease (types of inflammatory bowel disease) or adenomas (also known as polyps). It aims to prevent cancer and prolong life by offering advice on identifying early bowel cancer in adults most at risk.

Clinical guideline Published March 2011

MIB132: Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease

Advice on the use of point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease

Medtech innovation briefing Published December 2017

Crohn's disease

Everything NICE has said on managing Crohn's disease in children, young people and adults in an interactive flowchart

NICE Pathway Published October 2012 Last updated January 2019

Ulcerative colitis

Everything NICE has said on managing ulcerative colitis in adults, children and young people in an interactive flowchart

NICE Pathway Published June 2013 Last updated February 2019

Irritable bowel syndrome in adults

Everything NICE has said on diagnosing and managing irritable bowel syndrome in adults in primary care in an interactive flowchart

NICE Pathway Published October 2012 Last updated October 2017

Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (DG11)

Evidence-based recommendations on faecal calprotectin diagnostic tests for inflammatory diseases of the bowel

Diagnostics guidance Published October 2013

Colonoscopic surveillance

Everything NICE has said on colonoscopic surveillance for people with inflammatory bowel disease or adenomas in an interactive flowchart.

NICE Pathway Published November 2011 Last updated November 2016

Natural history of progression to colorectal cancer in people at increased risk:- What is the natural history of progression to colorectal cancer in people with inflammatory bowel disease (IBD) or adenomas?

history of progression to colorectal cancer in people with inflammatory bowel disease (IBD) or adenomas? Any explanatory...

Research recommendation Published June 2015

PredictSURE IBD to guide personalised treatment of Crohn's disease (provisional title)

In development [GID-DG10029] Expected publication date: 08 July 2020

Diagnostics guidance In development

Join a committee

Take an active role in producing a NICE guideline or quality standard.

Published March 2019

Surveillance programmes for people at increased risk of colorectal cancer:- How effective are colonoscopic surveillance programmes in improving overall survival and cancer-related survival in people at increased risk of colorectal cancer?

Although there is some observational evidence in people with inflammatory bowel disease (IBD), there is no evidence in...

Research recommendation Published June 2015

Irritable bowel syndrome in adults (QS114)

This quality standard covers diagnosing and managing irritable bowel syndrome in adults. It describes high-quality care in priority areas for improvement.

Quality standard Published February 2016

Spondyloarthritis in over 16s: diagnosis and management (NG65)

This guideline covers diagnosing and managing spondyloarthritis that is suspected or confirmed in adults who are 16 years or older. It aims to raise awareness of the features of spondyloarthritis and provide clear advice on what action to take when people with signs and symptoms first present in healthcare settings. It also provides advice on the range of treatments available.

NICE guideline Published February 2017 Last updated June 2017

Effectiveness of biomarkers for determining level of risk of colorectal cancer:- Which biomarkers, including epigenic and genetic markers, are predictors of colorectal cancer? How should these be used to improve risk stratification?

and genetic markers, for colorectal cancer in people with inflammatory bowel disease (IBD) or adenomas. Research should be...

Research recommendation Published June 2015

Ulcerative colitis: management (CG166)

This guideline covers the care and treatment of adults, children and young people who have ulcerative colitis (UC). It aims to help professionals to provide consistent high-quality care and it highlights the importance of advice and support for people with ulcerative colitis.

Clinical guideline Published June 2013

Patient experience in adult NHS services

Everything NICE has said on improving the experience of care for people using adult NHS services in an interactive flowchart

NICE Pathway Published March 2012 Last updated December 2017

Extracorporeal photopheresis for Crohn's disease (IPG288)

Evidence-based recommendations on extracorporeal photopheresis (treated white blood cells) for Crohn's disease

Interventional procedures guidance Published February 2009

MIB104: NaviCam for diagnosing gastrointestinal tract conditions

Advice on the use of NaviCam for diagnosing gastrointestinal (GI) tract and small bowel conditions to aid local decision-making

Medtech innovation briefing Published May 2017

Faecal incontinence in adults: management (CG49)

This guideline covers assessing and managing faecal incontinence (any involuntary loss of faeces that is a social or hygienic problem) in people aged 18 and over. It aims to ensure that staff are aware that faecal incontinence is a sign or a symptom, not a diagnosis.

Clinical guideline Published June 2007

Radially emitting laser fibre treatment of an anal fistula (IPG644)

Evidence-based recommendations on radially emitting laser fibre treatment of an anal fistula in adults

Interventional procedures guidance Published March 2019

KTT15: Biosimilar medicines

infliximab: a successful managed switch programme in people with inflammatory bowel disease discusses the outcomes of a managed...

Key therapeutic topic Published February 2016 Last updated February 2018

Osteoporosis: assessing the risk of fragility fracture (CG146)

This guideline covers assessing the risk of fragility fracture in people aged 18 and over with osteoporosis. It aims to provide guidance on the selection and use of risk assessment tools in the care of adults at risk of fragility fractures in all NHS settings.

Clinical guideline Published August 2012 Last updated February 2017

Shared learning award winners and finalists

A faecal calprotectin care pathway to support diagnosing inflammatory bowel diseases in primary care Yorkshire and Humber AHSN Download...

Published February 2019

Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care (DG30)

Evidence-based recommendations on quantitative faecal immunochemical tests (OC Sensor, HM-JACKarc and FOB Gold) to guide GP referral for colorectal cancer

Diagnostics guidance Published July 2017

Insertion of a collagen plug to close an abdominal wall enterocutaneous fistula (IPG507)

Evidence-based recommendations on inserting a collagen plug to close an abdominal wall enterocutaneous fistula

Interventional procedures guidance Published November 2014

Faecal incontinence in adults (QS54)

This quality standard covers managing faecal (bowel) incontinence in adults (aged 18 and over) in the community (at home and in care homes) and in all hospital departments. It includes assessment of bowel control problems, advice and support, and treatment options. It describes high-quality care in priority areas for improvement.

Quality standard Published February 2014

ESNM1: Clostridium difficile infection: fidaxomicin

Summary of the evidence on fidaxomicin for treating Clostridium difficile (C. diff/C. difficile) infection to inform local NHS planning and decision-making

Evidence summary Published July 2012

Negative pressure wound therapy for the open abdomen (IPG467)

Evidence-based recommendations on negative pressure (vacuum therapy) wound therapy for the open (exposed) abdomen to aid healing

Interventional procedures guidance Published November 2013

Irritable bowel syndrome in adults: diagnosis and management (CG61)

This guideline covers diagnosing and managing irritable bowel syndrome (IBS) in people aged 18 and over. It details how to accurately diagnose IBS, and aims to improve the quality of life for adults with IBS by promoting effective management using dietary and lifestyle advice, pharmacological therapy and referral for psychological interventions.

Clinical guideline Published February 2008 Last updated April 2017

Crohn's disease: management (CG152)

This guideline covers the management of Crohn’s disease in children, young people and adults. It aims to reduce people’s symptoms and maintain or improve their quality of life.

Clinical guideline Published October 2012 Last updated May 2016

Spondyloarthritis (QS170)

This quality standard covers diagnosing and managing spondyloarthritis in adults aged 16 and over. It describes high-quality care in priority areas for improvement.

Quality standard Published June 2018

Tofacitinib for moderately to severely active ulcerative colitis (TA547)

Evidence-based recommendations on tofacitinib (Xeljanz) for previously treated moderately to severely active ulcerative colitis in adults

Technology appraisal guidance Published November 2018

ESNM58: Ulcerative colitis: budesonide multimatrix (Cortiment)

Summary of the evidence on budesonide multimatrix (Cortiment) for treating ulcerative colitis (UC) to inform local NHS planning and decision-making

Evidence summary Published June 2015

Faecal incontinence

Everything NICE has said on managing faecal incontinence in adults in an interactive flowchart

NICE Pathway Published February 2013 Last updated January 2019

Ustekinumab for moderately to severely active Crohn's disease after previous treatment (TA456)

Evidence-based recommendations on ustekinumab (Stelara) for previously treated moderately to severely active Crohn’s disease in adults

Technology appraisal guidance Published July 2017

Osteoporosis

Everything NICE has said on assessing the risk of, preventing and treating osteoporotic fragility fractures in adults in an interactive flowchart

NICE Pathway Published August 2012 Last updated February 2018

Spondyloarthritis

Everything NICE has said on diagnosing and managing spondyloarthritis in people aged 16 and over in an interactive flowchart

NICE Pathway Published February 2017 Last updated March 2019

Eluxadoline for treating irritable bowel syndrome with diarrhoea (TA471)

Evidence-based recommendations on eluxadoline (Truberzi) for treating irritable bowel syndrome (IBS) with diarrhoea in adults

Technology appraisal guidance Published August 2017

MIB126: Promonitor for monitoring response to biologics in rheumatoid arthritis

Advice on Promonitor to monitor response to biologics (etanercept, infliximab and its biosimilars, adalimumab, rituximab, golimumab) in rheumatoid arthritis to

Medtech innovation briefing Published October 2017

Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy (TA352)

Evidence-based recommendations on vedolizumab (Entyvio) for moderately to severely active Crohn's disease if TNF-alpha therapy has not worked or...

Technology appraisal guidance Published August 2015

ESUOM30: Pouchitis: rifaximin

Summary of the evidence on rifaximin for treating pouchitis to inform local NHS planning and decision-making

Evidence summary Published March 2014